EtcobaƱez, Chenee T.
HRN: 03-36-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2023
METRONIDAZOLE 500MG (TAB)
11/27/2023
12/04/2023
PO
500mg
TID X 7 Days
AGE With Mild Dehydration
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes